Align Technology Sale Purchase Of Stock Over Time
| ALGN Stock | USD 211.06 2.52 1.18% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out Align Technology Performance and Align Technology Correlation. Align |
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Align Technology. If investors know Align will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Align Technology listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.02) | Earnings Share 5.87 | Revenue Per Share 52.669 | Quarterly Revenue Growth 0.018 | Return On Assets 0.067 |
The market value of Align Technology is measured differently than its book value, which is the value of Align that is recorded on the company's balance sheet. Investors also form their own opinion of Align Technology's value that differs from its market value or its book value, called intrinsic value, which is Align Technology's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Align Technology's market value can be influenced by many factors that don't directly affect Align Technology's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Align Technology's value and its price as these two are different measures arrived at by different means. Investors typically determine if Align Technology is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Align Technology's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Cross Equities Sale Purchase Of Stock Analysis
Compare Align Technology and related stocks such as Insulet, Tandem Diabetes Care, and Abbott Laboratories Sale Purchase Of Stock Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| PODD | 4.5 M | 4.5 M | (1.5 M) | (3.3 M) | (8.7 M) | (2.6 M) | (2.9 M) | (4.1 M) | (17.8 M) | (8.6 M) | (29.8 M) | (28.2 M) | (16.8 M) | 10.6 M | 11.1 M |
| TNDM | 3.7 M | 3.7 M | 3.7 M | 3.7 M | 3.7 M | 3.4 M | 2.3 M | 570 K | 32 M | 24.2 M | 69.8 M | 51.9 M | 17.6 M | 20.2 M | 25.1 M |
| ABT | (289.5 M) | (77 M) | (2.4 B) | (1.6 B) | (2.2 B) | (2.2 B) | (522 M) | (827 M) | (238 M) | (718 M) | (403 M) | (2.3 B) | (3.8 B) | (1.2 B) | (1.3 B) |
| SYK | (3.1 M) | (622 M) | (108 M) | (317 M) | (100 M) | (700 M) | (13 M) | (230 M) | (300 M) | (307 M) | (110 M) | (114 M) | (122 M) | (155 M) | (162.8 M) |
| BSX | (57.4 M) | (492 M) | (600 M) | (500 M) | (125 M) | 114 M | 111 M | 85 M | 101 M | 123 M | (535 M) | 110 M | 136 M | 182 M | 191.1 M |
| TMDX | 63.6 M | 63.6 M | 63.6 M | 63.6 M | 63.6 M | 63.6 M | 63.6 M | 3 K | 46 K | 202 K | 357 K | 419 K | 509 K | 955 K | 907.2 K |
| INSP | 42 K | 42 K | 42 K | 42 K | 42 K | 42 K | 12.8 M | 25.2 M | 182.4 M | 1.4 M | 2.4 M | 3.5 M | (43 K) | (17.2 M) | (16.3 M) |
| NARI | 27 M | 27 M | 27 M | 27 M | 27 M | 27 M | 27 M | 27 M | 27 M | 127.2 K | (25 K) | (2.4 M) | (6.5 M) | (9.6 M) | (9.1 M) |
| INMD | 38 K | 38 K | 38 K | 38 K | 38 K | 38 K | 38 K | 56 K | 186 K | 70.2 M | (17.2 M) | (35.4 M) | (42.6 M) | 0.0 | 0.0 |
| PEN | (9.4 M) | (9.4 M) | (9.4 M) | (9.4 M) | (9.4 M) | (2.5 M) | (2.6 M) | (11.7 M) | (17.7 M) | (18.5 M) | (10.1 M) | (15.8 M) | (8 M) | (2.1 M) | (2.2 M) |
Align Technology and related stocks such as Insulet, Tandem Diabetes Care, and Abbott Laboratories Sale Purchase Of Stock description
My Equities
My Current Equities and Potential Positions
| Align Technology | ALGN |
| Classification | Cannabis |
| Location | California; U.S.A |
| Exchange | NASDAQ Exchange |
USD 211.06
Check out Align Technology Performance and Align Technology Correlation. To learn how to invest in Align Stock, please use our How to Invest in Align Technology guide.You can also try the Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas.
Align Technology technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.